Literature DB >> 35567707

Influence of Tangeretin on the Exponential Regression of Inflammation and Oxidative Stress in Streptozotocin-Induced Diabetic Nephropathy.

Pei Sun1, Ran Huang2, Zifu Qin3, Fang Liu4.   

Abstract

Diabetes is an amalgamation of metabolic disorders marked by hyperglycemia. Over time diabetes brings up several other complications with it like cardiovascular disease, retinopathy, neuropathy, and nephropathy. among which diabetic nephropathy (DN) is the one we are concerned about in the present study. Diabetes management requires following a healthy lifestyle with proper medication. Most of the anti-diabetic drugs available at present come with adverse side effects. Nature has provided us with several components that are anti-diabetic in nature which has fewer or no side effects and tangeretin is one among them. Tangeretin is a natural flavonoid abundantly present in orange peel and tangerines. Our study is designed to evaluate tangeretin, as an anti-diabetic medication especially for patients suffering from diabetic nephropathy. The procured healthy rats were first divided into four groups: the group I was maintained as healthy control and the others were subjected to the induction of diabetes by i.p. injection of streptozotocin (STZ) at the concentration of 55mg/kg b.wt .Then, the diabetic rats were further divided into three groups: group II was used as the diabetic control rats and the group III and group IV were administered with tangeretin (25mg/kg b.wt) and positive control drug metformin (150mg/kg b.wt) for 8 weeks. The body weight, blood glucose, and serum insulin levels were estimated at week 0 and week 8. Reactive oxygen species (ROS) inhibitory effect, antioxidant, antilipidemic, nephroprotective, and anti-inflammatory effects of tangeretin on the diabetic-induced rats were evaluated at the end of week 8 in addition to the histopathological assessment of the sections of the kidneys of the experimental rats. All the test results concluded that tangeretin was able to significantly decelerate the progression of DN in STZ-induced diabetic rats.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Anti-inflammatory; Antilipidemic; Antioxidant; Diabetic nephropathy; Metformin; Nephroprotective; ROS; Tangeretin

Mesh:

Substances:

Year:  2022        PMID: 35567707     DOI: 10.1007/s12010-022-03920-w

Source DB:  PubMed          Journal:  Appl Biochem Biotechnol        ISSN: 0273-2289            Impact factor:   3.094


  40 in total

Review 1.  How to prevent the microvascular complications of type 2 diabetes beyond glucose control.

Authors:  Willy Marcos Valencia; Hermes Florez
Journal:  BMJ       Date:  2017-01-17

Review 2.  Diabetic kidney disease.

Authors:  Merlin C Thomas; Michael Brownlee; Katalin Susztak; Kumar Sharma; Karin A M Jandeleit-Dahm; Sophia Zoungas; Peter Rossing; Per-Henrik Groop; Mark E Cooper
Journal:  Nat Rev Dis Primers       Date:  2015-07-30       Impact factor: 52.329

3.  Beneficial effects of mangiferin isolated from Salacia chinensis on biochemical and hematological parameters in rats with streptozotocin-induced diabetes.

Authors:  Periyar Selvam Sellamuthu; Palanisamy Arulselvan; Sharida Fakurazi; Murugesan Kandasamy
Journal:  Pak J Pharm Sci       Date:  2014-01       Impact factor: 0.684

Review 4.  Use of metformin in the setting of mild-to-moderate renal insufficiency.

Authors:  Kasia J Lipska; Clifford J Bailey; Silvio E Inzucchi
Journal:  Diabetes Care       Date:  2011-06       Impact factor: 19.112

5.  Evaluation of wound healing properties of bioactive aqueous fraction from Moringa oleifera Lam on experimentally induced diabetic animal model.

Authors:  Abubakar Amali Muhammad; Palanisamy Arulselvan; Pike See Cheah; Farida Abas; Sharida Fakurazi
Journal:  Drug Des Devel Ther       Date:  2016-05-24       Impact factor: 4.162

6.  Tangeretin has anti-asthmatic effects via regulating PI3K and Notch signaling and modulating Th1/Th2/Th17 cytokine balance in neonatal asthmatic mice.

Authors:  L-L Liu; F-H Li; Y Zhang; X-F Zhang; J Yang
Journal:  Braz J Med Biol Res       Date:  2017-07-20       Impact factor: 2.590

Review 7.  Phytobioactive compound-based nanodelivery systems for the treatment of type 2 diabetes mellitus - current status.

Authors:  Palanivel Ganesan; Palanisamy Arulselvan; Dong-Kug Choi
Journal:  Int J Nanomedicine       Date:  2017-02-09

8.  Metformin acutely lowers blood glucose levels by inhibition of intestinal glucose transport.

Authors:  Olga Horakova; Petra Kroupova; Kristina Bardova; Jana Buresova; Petra Janovska; Jan Kopecky; Martin Rossmeisl
Journal:  Sci Rep       Date:  2019-04-16       Impact factor: 4.379

Review 9.  Flavonoids as natural phenolic compounds and their role in therapeutics: an overview.

Authors:  Rakesh E Mutha; Anilkumar U Tatiya; Sanjay J Surana
Journal:  Futur J Pharm Sci       Date:  2021-01-20

10.  Emerging therapies for diabetic nephropathy patients: beyond blockade of the Renin-Angiotensin system.

Authors:  Bassem Y Tanios; Fuad N Ziyadeh
Journal:  Nephron Extra       Date:  2012-10-30
View more
  1 in total

Review 1.  Mechanism of Citri Reticulatae Pericarpium as an Anticancer Agent from the Perspective of Flavonoids: A Review.

Authors:  Li Song; Peiyu Xiong; Wei Zhang; Hengchang Hu; Songqi Tang; Bo Jia; Wei Huang
Journal:  Molecules       Date:  2022-08-31       Impact factor: 4.927

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.